Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.23736/S0392-0488.17.05600-0 | DOI Listing |
Med Mycol Case Rep
December 2024
Dermatology Unit, Department of Systems Medicine, University of Rome "Tor Vergata", 00133, Rome, Italy.
Psoriasis is a multifactorial immune-mediated disorder linked to the interleukin (IL)-17 signalling pathway. We present an unusual case of and caused by that developed after starting the IL-17A/F inhibitor bimekizumab. Our case underlines how psoriatic patients, treated with IL-17 inhibitors, should be screened for cutaneous fungal infections before and during treatment, in order to exclude a concomitant infection or the risk of its exacerbation.
View Article and Find Full Text PDFSci Rep
September 2024
Department of Dermatology, Venereology and Andrology, Medical Research and Clinical Studies Institute, National Research Centre, Giza, Egypt.
J Am Acad Dermatol
January 2025
Department of Dermatology, Weill Cornell Medicine, New York, New York. Electronic address:
Mycoses
April 2024
Department of Dermatology, Peking University First Hospital, Beijing, China.
Lasers Med Sci
January 2024
Albert Einstein College of Medicine, Montefiore Medical Center, 1300 Morris Park Ave, Bronx, NY, 10461, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!